ORIGINAL RESEARCH article
Front. Cell. Neurosci.
Sec. Cellular Neuropathology
Volume 19 - 2025 | doi: 10.3389/fncel.2025.1557645
This article is part of the Research TopicNeuro-immune interaction in diseaseView all articles
Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson's disease and related disorders
Provisionally accepted- 1ASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, United States
- 2Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. Neuron-to-microglia communication via fractalkine (CX3CL1) and its receptor plays a significant role in neuroinflammation. The relationship between fractalkine signaling and neuroinflammatory activities has been studied in animal models of PD, but its role is unclear in human PD. The current study aimed to elucidate the neuron-microglia communication between neuronal and endothelial fractalkine ligand expression, microglial activity, and CD4+ T cell infiltration during the development of PD. Methods: Brain sections were obtained from age-matched control subjects with no motor deficits (control, n=8), mild motor deficits with nigral Lewy bodies (MMD-LB, n=8) without a clinical diagnosis of PD, individuals with a clinical diagnosis of sporadic PD (n=13), and progressive supranuclear palsy patients (PSP, n=9). We performed quantitative stereological analyses and optical metrology of fractalkine expression in neurons and endothelial cells and immunoreactivities of microglial and CD4+ T cells within the substantia nigra of PD cases. These data were compared with findings seen in age-matched controls as well as MMD-LB and PSP. Results: In PD, MMD-LB, and PSP postmortem brains, fractalkine expression in remaining nigral neurons was significantly reduced but markedly increased in blood vessel endothelial cells. The density of microglia and CD4+ T cells in the substantia nigra was significantly higher in these disorders when compared to controls. The decline in neuronal fractalkine expression was inversely correlated with increases in microglial numbers in the substantia nigra, while higher levels of fractalkine in endothelial cells were positively correlated with CD4+ cells infiltrating the injured substantia nigra across groups. Both PD and PSP groups displayed a similar pattern of neuroinflammatory changes.Discussion: The downregulation of neuronal fractalkine expression caused by protein inclusions, such as abnormal alpha-synuclein or tau, is linked to microglia activation. When activated, microglia release cytokines that further stimulate endothelial cells to express fractalkine. This process recruits peripheral T cells, which infiltrate the injured brain. These findings indicate that the varying levels of neuronal and endothelial fractalkine expression in the substantia nigra contribute to neuroinflammatory activity in both synucleinopathy and tauopathy.
Keywords: neuron-microglia communication, Neuroinflammation, Microglia, CD4 + T lymphocyte, neurodegenerative disease
Received: 08 Jan 2025; Accepted: 24 Jun 2025.
Copyright: © 2025 Chu, Harms, Boehringer and Kordower. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jeffrey Kordower, ASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.